Results 1 to 10 of about 78,184 (307)

BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders [PDF]

open access: yesBiomolecules
BTK (Bruton’s tyrosine kinase) has become a key therapeutic target across several hematologic diseases, beginning with its original use in CLL/SLL.
Andrea Duminuco   +9 more
doaj   +2 more sources

Inhibition of bruton’s tyrosine kinase directly alleviates pathogenic CD4+ T cell response via PPAR-γ signaling in autoimmune uveitis [PDF]

open access: yesJournal of Neuroinflammation
Background Bruton’s tyrosine kinase (BTK), a key regulator of immune responses, has been extensively studied in B cells and innate immunocytes. Small-molecule BTK inhibitors (BTKi) have shown remarkable efficacy in multiple preclinical and clinical ...
Zhiqiang Xiao   +13 more
doaj   +2 more sources

SY-1530, a highly selective BTK inhibitor, effectively treats B-cell malignancies by blocking B-cell activation

open access: yesCancer Biology & Medicine, 2022
Objective: B-cell antigen receptor (BCR) signaling is required to maintain the physiological functions of normal B cells and plays an important pathogenic role in B-cell malignancies. Bruton tyrosine kinase (BTK), a critical mediator of BCR signaling, is
Liao Wang   +7 more
doaj   +1 more source

Megjegyzések a lokális Craig interpolációhoz

open access: yesElpis, 2022

Zalán Molnár, Övge Öztürk
doaj   +1 more source

Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases

open access: yesPlatelets, 2021
Antiplatelet medications comprise the cornerstone of treatment for diseases that involve arterial thrombosis, including acute coronary syndromes (ACS), stroke and peripheral arterial disease.
Maan H. Harbi   +4 more
doaj   +1 more source

Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2022
Bruton tyrosine kinase (BTK) is linked to multiple signalling pathways that regulate cellular survival, activation, and proliferation. A covalent BTK inhibitor has shown favourable outcomes for treating B cell malignant leukaemia.
Tony Eight Lin   +10 more
doaj   +1 more source

Egyetemi hallgatók környezettudatossága a materializmus, az élettel való elégedettség, a politikai, illetve a pandémiával kapcsolatos nézeteik függvényében

open access: yesMetszetek, 2022
Az elmúlt évtizedekben egyre nagyobb figyelmet kap a környezeti problémák és az ezzel ös - szefüggő társadalmi jelenségek vizsgálata. Az egyetemi hallgatók környezettudatosságának és környezettudatosságukat befolyásoló tényezőknek a megismerése ...
Ferenc Mónus   +2 more
doaj   +1 more source

Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors

open access: yesExploration of Targeted Anti-tumor Therapy, 2020
Chronic lymphocytic leukemia is a common form of leukemia and is dependent on growth-promoting signaling via the B-cell receptor. The Bruton tyrosine kinase (BTK) is an important mediator of B-cell receptor signaling and the irreversible BTK inhibitor ...
Rachael Arthur   +3 more
doaj   +1 more source

Stimulation of the catalytic activity of the tyrosine kinase Btk by the adaptor protein Grb2

open access: yeseLife, 2023
The Tec-family kinase Btk contains a lipid-binding Pleckstrin homology and Tec homology (PH-TH) module connected by a proline-rich linker to a ‘Src module’, an SH3-SH2-kinase unit also found in Src-family kinases and Abl. We showed previously that Btk is
Laura M Nocka   +4 more
doaj   +1 more source

Bruton’s Tyrosine Kinase in Neutrophils Is Crucial for Host Defense against Klebsiella pneumoniae

open access: yesJournal of Innate Immunity, 2022
Humans with dysfunctional Bruton’s tyrosine kinase (Btk) are highly susceptible to bacterial infections. Compelling evidence indicates that Btk is essential for B cell-mediated immunity, whereas its role in myeloid cell-mediated immunity against ...
Zhe Liu   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy